CVS Group CEO, Richard Fairman, CFO, Robin Alfonso and COO, Ben Jacklin present the interim results for the period ended 31 December 2021. Another strong set of results, with demand for their services continuing to increase. The positive trading momentum in H1 2022 has continued into the first two months of the second half and they are well placed to continue to invest and acquire to deliver further future growth.
Richard Fairman, CEO
00:17 – Introduction & Agenda
01:05 – Growth strategy
02:44 – Half Year highlights
04:34 – Business model
05:34 – Market dynamics
06:24 – Opportunity for further acquisitions
09:02 – ESG
Robin Alfonso, CFO
09:26 – Financial summary
11:40 – Revenue growth
13:05 – EBITDA growth
13:47 – Highly cash generative
14:39 – Deploying capital
15:28 – Investing in practices
16:09 – Greenfield opportunity
Ben Jacklin, COO
16:47 – Strategic update
Richard Fairman, CEO
24:39 – Current trading and outlook
CVS Group plc (CVS) is a veterinary services provider. The Company operates in the four business segments, namely Veterinary Practices, Laboratories, Crematoria and Online Retail Business. It offers an integrated model with approximately 500 veterinary practices across its three territories, including eight specialist referral hospitals and 34 out-of-hours sites. Veterinary Practices provide specialist treatment for companion, equine and farm animals. The Company laboratories provide diagnostic services to CVS veterinary practices and third parties. It offers a range of tests with the ability to tailor specific profiles to its customers' needs. Its crematoria provide pet cremation and clinical waste services to CVS practices and third-party practices, and cremations to animal owners. CVS online retail business, Animed Direct, sells prescription and nonprescription medicines, pet foods and a range of pet care products.
